Loading clinical trials...
Loading clinical trials...
An Evaluator-blinded, Randomized Within-subject Repeat Insult Study to Evaluate Potential Skin Irritation and Sensitization of HP-5000 (Diclofenac Sodium Topical System) in Healthy Adults
Conditions
Interventions
HP-5000 Topical Patch
HP-5000 Placebo Patch
+1 more
Locations
1
United States
TKL Research
Fair Lawn, New Jersey, United States
Start Date
June 3, 2021
Primary Completion Date
March 8, 2022
Completion Date
March 11, 2022
Last Updated
August 23, 2022
NCT06927934
NCT01820650
NCT04145011
NCT01899508
NCT03349645
NCT02024529
Lead Sponsor
Noven Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions